MSB 2.67% 96.0¢ mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-143

  1. 7,294 Posts.
    lightbulb Created with Sketch. 564
    Like slways bell potter snd Mornington shouldreveive a prize of miss completlyvthe point.

    forget covid!!!!

    ARDS is a disease that have dozens of other main diseases that cause ards.

    our agreement with novartis cover that !

    we are not with q100m like bell potter suggest in our hand

    we are with 1,000m

    juputer post yesterday address much better the subject

    CATo
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.